Impact of Oxidative Stress on Myocardial Performance in Patients with Diabetes: a Focus on Subclinical Left Ventricular Dysfunction

Overview

Journal BMJ Open Diabetes Res Care

Specialty Endocrinology

Date 2024 Jun 17

PMID 38886070

Authors

Dogac Oksen

Muzaffer Aslan

Affiliations

Soon will be listed here.

Abstract

Introduction: Oxidative stress is known to affect left ventricular functions negatively. There is a strong bidirectional connection between diabetes mellitus (DM) and oxidative stress. In parallel, left ventricular dysfunction is observed more frequently, even in patients with DM without other risk factors. In this context, the objective of this study is to comparatively investigate the potential relationship between oxidative stress and subclinical left ventricular dysfunction (SCLVD) assessed by Myocardial Performance Index (MPI) in patients with and without DM.

Research Design And Methods: The sample of this observational cross-sectional single-center study consisted of 151 patients who were evaluated for oxidative stress and SCLVD by tissue Doppler echocardiography. Patients' total oxidant status (TOS), total antioxidant status (TAS), and Oxidative Stress Index (OSI) values were calculated. The effects of oxidative stress and DM on MPI were analyzed.

Results: There were 81 patients with DM (mean age: 46.17±10.33 years) and 70 healthy individuals (mean age: 45.72±9.04 years). Mean TOS and OSI values of the DM group were higher than healthy individuals (5.72±0.55 vs 5.31±0.50, p = <0.001; and 4.92±1.93 vs 1.79±0.39, p = <0.001; respectively). The mean TAS value of the DM group was significantly lower than the healthy group (1.21±0.40 vs 3.23±0.51, p = <0.001). There was a significant correlation between OSI and MPI mitral in the DM group (R 0.554, p = <0.001) but not in the healthy group (R -0.069, p=0.249).

Conclusions: Both oxidative stress and myocardial dysfunction were found to be more common in patients with DM. The study's findings indicated the negative effect of oxidative stress on myocardial functions. Accordingly, increased oxidative stress caused more significant deterioration in MPI in patients with DM compared with healthy individuals.

References

Tei C, Ling L, Hodge D, Bailey K, Oh J, Rodeheffer R . New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function--a study in normals and dilated cardiomyopathy. J Cardiol. 1995; 26(6):357-66. View

Gungor Kaya M, Simsek Z, Sarli B, Buyukoglan H . Myocardial performance index for detection of subclinical abnormalities in patients with sarcoidosis. J Thorac Dis. 2014; 6(5):429-37. PMC: 4015014. DOI: 10.3978/j.issn.2072-1439.2014.03.19. View

Einarson T, Acs A, Ludwig C, Panton U . Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol. 2018; 17(1):83. PMC: 5994068. DOI: 10.1186/s12933-018-0728-6. View

Turfan M, Akyel A, Bolayir H, Vatankulu M, Akturk M, Yetkin I . Correlation of the myocardial performance index with plasma B-type natriuretic peptide levels in type 2 diabetes mellitus and impaired glucose tolerance. Kardiol Pol. 2012; 70(6):556-62. View

Huynh K, Kiriazis H, Du X, Love J, Jandeleit-Dahm K, Forbes J . Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes. Diabetologia. 2012; 55(5):1544-53. DOI: 10.1007/s00125-012-2495-3. View

Pham I, Cosson E, Nguyen M, Banu I, Genevois I, Poignard P . Evidence for a Specific Diabetic Cardiomyopathy: An Observational Retrospective Echocardiographic Study in 656 Asymptomatic Type 2 Diabetic Patients. Int J Endocrinol. 2015; 2015:743503. PMC: 4444596. DOI: 10.1155/2015/743503. View

Moller J, Sondergaard E, Poulsen S, Egstrup K . The Doppler echocardiographic myocardial performance index predicts left-ventricular dilation and cardiac death after myocardial infarction. Cardiology. 2001; 95(2):105-11. DOI: 10.1159/000047355. View

Grigorescu E, Lacatusu C, Floria M, Mihai B, Cretu I, Sorodoc L . Left Ventricular Diastolic Dysfunction in Type 2 Diabetes-Progress and Perspectives. Diagnostics (Basel). 2019; 9(3). PMC: 6787758. DOI: 10.3390/diagnostics9030121. View

de Simone G, Devereux R, Chinali M, Lee E, Galloway J, Barac A . Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study. J Hypertens. 2009; 28(2):353-60. PMC: 3005764. DOI: 10.1097/HJH.0b013e3283331169. View

10.

Anusruti A, Xuan Y, Gao X, Jansen E, Laetsch D, Brenner H . Factors associated with high oxidative stress in patients with type 2 diabetes: a meta-analysis of two cohort studies. BMJ Open Diabetes Res Care. 2020; 8(1). PMC: 7039603. DOI: 10.1136/bmjdrc-2019-000933. View

11.

Sartori M, Conti F, Dias D, Dos Santos F, Machi J, Palomino Z . Association between Diastolic Dysfunction with Inflammation and Oxidative Stress in Females ob/ob Mice. Front Physiol. 2017; 8:572. PMC: 5572327. DOI: 10.3389/fphys.2017.00572. View

12.

Somaratne J, Whalley G, Bagg W, Doughty R . Early detection and significance of structural cardiovascular abnormalities in patients with Type 2 diabetes mellitus. Expert Rev Cardiovasc Ther. 2007; 6(1):109-25. DOI: 10.1586/14779072.6.1.109. View

13.

Ernande L, Bergerot C, Rietzschel E, De Buyzere M, Thibault H, Pignonblanc P . Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy?. J Am Soc Echocardiogr. 2011; 24(11):1268-1275.e1. DOI: 10.1016/j.echo.2011.07.017. View

14.

Andersen N, Poulsen S, Helleberg K, Ivarsen P, Knudsen S, Mogensen C . Impact of essential hypertension and diabetes mellitus on left ventricular systolic and diastolic performance. Eur J Echocardiogr. 2003; 4(4):306-12. DOI: 10.1016/s1525-2167(03)00034-9. View

15.

Tei C, Nishimura R, Seward J, Tajik A . Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr. 1997; 10(2):169-78. DOI: 10.1016/s0894-7317(97)70090-7. View

16.

Parsaee H, Nabati M, Azizi S, Yazdani J . Correlation between albuminuria and tissue Doppler-derived left ventricular myocardial performance index in patients with type 2 diabetes. J Clin Ultrasound. 2021; 49(5):472-478. DOI: 10.1002/jcu.22980. View

17.

Luc K, Schramm-Luc A, Guzik T, Mikolajczyk T . Oxidative stress and inflammatory markers in prediabetes and diabetes. J Physiol Pharmacol. 2020; 70(6). DOI: 10.26402/jpp.2019.6.01. View

18.

Manganaro R, Marchetta S, Dulgheru R, Sugimoto T, Tsugu T, Ilardi F . Correlation between non-invasive myocardial work indices and main parameters of systolic and diastolic function: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging. 2019; 21(5):533-541. DOI: 10.1093/ehjci/jez203. View

19.

Dantas A, Fortes Z, de Carvalho M . Vascular disease in diabetic women: Why do they miss the female protection?. Exp Diabetes Res. 2012; 2012:570598. PMC: 3438753. DOI: 10.1155/2012/570598. View

20.

Withers S, Agabiti-Rosei C, Livingstone D, Little M, Aslam R, Malik R . Macrophage activation is responsible for loss of anticontractile function in inflamed perivascular fat. Arterioscler Thromb Vasc Biol. 2011; 31(4):908-13. DOI: 10.1161/ATVBAHA.110.221705. View